Seoul, South Korea

Seong-Pyo Park

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Seong-Pyo Park: Innovator in Cancer Research

Introduction

Seong-Pyo Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of diagnostic and therapeutic applications for acute leukemia and lymphoblastic lymphoma. With a total of 6 patents, his work is recognized for its potential impact on medical science.

Latest Patents

One of his latest patents is titled "Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof." This invention relates to a CD43 epitope expressed on human acute leukemia and lymphoblastic lymphoma cells, which is not present on mature hematopoietic cells, hematopoietic stem cells, and non-hematopoietic cells. The patent outlines its diagnostic and therapeutic applications for these types of cancer. Another significant patent is "Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof." This invention describes an antibody that binds to human intercellular adhesion molecule-1 (ICAM-1), which can modulate the differentiation status of dendritic cells and prolong graft survival. It also includes a pharmaceutical composition comprising the antibody and methods for its use in treating diseases.

Career Highlights

Seong-Pyo Park is currently associated with Dinona Inc., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of complex diseases.

Collaborations

He collaborates with notable colleagues, including Seong-Hoe Park and Kyeong-Cheon Jung, who share his commitment to advancing medical research and innovation.

Conclusion

Seong-Pyo Park's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work has the potential to significantly impact the diagnosis and treatment of acute leukemia and lymphoblastic lymphoma.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…